A mechanism developed by the Stop TB Partnership to expand access to, and availability of, high quality TB drugs to facilitate DOTS expansion. Established in 2001, the GDF is housed in World Health Organization (WHO) headquarters in Geneva and managed by a small team in the Stop TB Partnership secretariat. It aims to provide TB drugs to treat up to ten million patients, and to help countries reach the WHO global control targets by 2005.
Alert: Global Health Learning content has found a new home. Please stay tuned.